| 9th AIDS Seminar in KUMAMOTO | ||
| 9th AIDS Seminar in KUMAMOTO Program ■ 18 September ■ 19 September ■ Poster Session |
||
| ■ Poster Session | ||
| P01
Terumasa Ikeda [Kumamoto Univ.] The anti-retroviral potency of APOBEC1 cytidine deaminase from small animal species P02 Eri Takeda [Kinki Univ.] An APOBEC3 isoform expressed in C57BL/6 mice exhibits a physiological restricting activity against Friend retrovirus infection and pathogenesis. P03 Taisuke Izumi [Kyoto Univ.] HIV-1 Vif Causes G2 Cell Cycle Arrest via the p53 Pathway P04 Mikako Fujita [Kumamoto Univ.] Functional analysis of HIV-2 Vpx protein P05 Noriyuki Okudaira [IMCJ] Retrotransposition of LINE-1 by HIV-1 Vpr. P06 Yuzuru Minemoto [IMCJ] An association between HIV-1 Vpr and Snf2h, a chromatin remodeling factor, facilitates viral integration into pericentromeric heterochromatin P07 Seiji Yamamoto [Kyoto Univ.] Functional association of HIV-1 and MoMLV integrase with HECT-domain ubiquitin ligase Huwe1 P08 Masateru Hiyoshi [Kumamoto Univ.] Dys-regulated activation of a Src tyrosine kinase Hck at the Golgi apparatus by Nef impairs protein Glycosylation and trafficking P09 Kenji Ohba [NIID] Follicular dendritic cells activate HIV-1 replication through a juxtacrine mechanism mediated by P-selectin glycoprotein ligand-1 P10 Shoukichi Takahama [Ehime Univ./NIID] "Atypical protein kinase C (aPKC), a cell polarity regulating kinase, phosphorylates HIV-1 Gag" P11 Ayumu Kuroishi [Osaka Univ.] Engineering of HIV-1 able to replicate in simian cells P12 Kenta Matsuda [Kyoto Univ.] Construction and in vivo analysis of R5 tropic SHIV P13 Yu-ya Mitsuki [NIID] "Selective transmission of R5 HIV-1 over X4 HIV-1at the dendritic cell?T cell infectious synapse is determined by the T cell activation state" P14 Keisuke Yusa [Kumamoto Univ.] The effect of virion incorporated CCR5 on R5 HIV-1 infectivity P15 Yosuke Maeda [Kumamoto Univ.] Analyses of post-entry restriction of HIV-1 infection in human T cell lines P16 Tetsuya Kimura [Kumamoto Univ.] Role of N-linked glycosylation in N-terminus region of V2 loop of HIV-1 gp120 for resistance to neutralization by anti-V3 antibody. P17 Chisato Narahara [Kumamoto Univ.] Different mutation in HIV-1 gp120 V3-tip region for escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection with low or high concentration of the Mab P18 Makiko Hatada [Kumamoto Univ.] The impact of an N-linked glycosylation site insertion in HIV-1 gp120 V2 region to escape from a potent neutralization anti-V3 monoclonal antibody P19 Jagdagsuren Davaalkham [IMCJ] High Risk Status of HIV-1 Infection in the Very Low Epidemic Country, Mongolia, 2007 P20 Tamayo Watanabe [IMCJ] Patterns of AIDS-related complications at the International Medical Center of Japan (IMCJ) in HAART era P21 Tsunefusa Hayashida [IMCJ] Analysis of new patients who visited ACC in 2003, 2007, and 2008 using BED assay P22 Tomomi Towata [Kumamoto Univ.] Inhibitory Effect of Drug-Free Hybrid Liposomes on Primary Effusion Lymphoma P23 Shinichiro Hattori [Kumamoto Univ.] Protection of CD4+ Cells against HIV-1 Infection by 4’-Ethynyl-2-Fluoro-2’- Deoxyadenosine in hu-PBMC NOD/SCID/Jak-3-KO AIDS mice P24 Manabu Aoki [Kumamoto Univ.] Role of Gag Mutations in HIV in Its Replication Fitness and Acquisition of Resistance to Protease Inhibitors P25 Masayuki Amano [Kumamoto Univ.] Spontaneous Degradation of Gag Proteins in Multi-drug-resistant HIV-1 Variants Containing Insertions in Gag Proteins P26 Takayuki Hamasaki [Kagoshima Univ.] In silico screening of anti-HIV-1 compounds targeting cyclin T1 P27 Naoki Kobayashi [Kumamoto Univ.] The immature differentiation of human T cells in humanized NOD/SCID/Jak3-/- mice P28 Takuya Yamamoto [NIID] SIV-specific functional T-cell induction after passive neutralizing antibody immunization postinfection P29 Tetsuya Kuwano [Univ. of Tokyo] Influence of MHC-I polymorphisms on the efficacy of a T cell-based vaccine in a macaque AIDS model P30 Yoshinori Fukazawa [Kyoto Univ.] Live attenuated AIDS vaccine conferred a strong protection against highly pathogenic SHIV challenge. P31 Katsuhisa Inaba [Kyoto Univ.] CD4+ cell reduction and enteropathy in small intestine can be occurred irrespective of viral load in simian/human immunodeficiency virus infection. P32 Kei Matsuki [Nagasaki Univ.] Fine mapping of epitope regions recognized by HIV-1-Specific Cytotoxic T Lymphocytes P33 Philip Mwimanzi [Kumamoto Univ]. The effects of CTL-escape conferring mutations on Nef's pathogenic functions in primary macrophages. P34 Chihiro Motozono [Kumamoto Univ.] The decay of peptide-MHC complex influences antiviral activity of HIV-specific CTLs P35 Nan Zheng [Kumamoto Univ.] Killing of HIV-1-infected CD4+ T cells and macrophages by an HIV-1 Nef-specific CD4+ CTL P36 Keiko Sakai [Kumamoto Univ.] HIV-1-induced homeostatic and developmental dysfunction of CD4+ T-cell subsets P37 Hayato Murakoshi [Kumamoto Univ.] Identification of HLA-B*4801-restricted HIV-1-Gag epitopes P38 Hirokazu Koizumi [Kumamoto Univ.] Different effects of HIV-1-specific CTLs having a strong ability to suppress HIV-1 replication on selection of escape mutant viruses P39 Nozomi Kuse [Kumamoto Univ.] Selection of HIV-1 escape mutants from HIV-1-specific CTLs in vitro HIV-1 replication assay P40 Kazutaka Honda [Kumamoto Univ.] Selection of escape mutant from HLA-Cw*1202-restricted cytotoxic T lymphocytes having a strong ability to suppress HIV-1 replication |
||
|
|
||
| ←18 Sep. | ||